- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06127589
The "Quit-for-Kids" Project: to Increase Abstinence and Protect Children From Tobacco Smoke Exposure
An Integrated Smoking Cessation Intervention Model of Brief Advice, Nicotine Replacement Therapy and Mobile Health Support for Smoking Parents to Increase Abstinence and Protect Children From Tobacco Smoke Exposure: A Randomized Controlled Trial
Study Overview
Status
Conditions
Detailed Description
Background: Around 40% of children worldwide were exposed to secondhand smoke (SHS). Despite reaching a single-digit smoking prevalence of 9.5% in 2022, about one in three children in Hong Kong (36.2%) are still exposed to SHS, mostly at home. Especially children from deprived households, suffer from a higher risk of more pervasive SHS exposure. Aim: The project aims to apply evidence-based interventions to increase smoking cessation and reduce SHS exposure in children of disadvantaged families. The specific objectives of the study are (1) to evaluate the effectiveness of a novel, family-based intervention model in increasing smoking cessation and reducing SHS exposure in children of disadvantaged families, (2) to alert parents in recognizing their child's exposure level and take actions in protecting their child from exposure, (3) to advocate for the adoption of this resource-efficient intervention model in Non-Governmental Organizations(NGOs), District Health Centre Express(DHC/Es), and other smoking cessation service providers in Hong Kong.
Methods: A family-based smoking cessation that collect comprehensive biochemical and environmental data of SHS exposure, and apply evidence-based interventions to prevent the SHS exposure and support quitting in deprived households. Two domains of outcome will be assessed: (1) Effectiveness and overall impact of smoking cessation intervention. (2) Cost-effectiveness analysis and qualitative interviews to estimate the scalability and mechanisms of interventions.
Procedure: Participants will be actively recruited through different channels including direct referral from Non-Governmental Organizations (NGOs) with social housing schemes, referral and recruitment from District Health Centre (DHC), community-based recruitment activities in smoking hotspots, and online advertisement on search engines and social media sites. The eligibility of smokers and non-smokers will be assessed by counselors and invited to join the randomized controlled trial and allocated to one of the groups of the smoking cessation intervention. 6 follow ups at 1 week, 1,2,3,6,12 months will be conducted to both smokers and non-smokers to reveal their SHS exposure level and smoker's quitting progress.
Hypothesis: We hypothesize that the assessment-guided intervention will lead to significant increases in rates of smoking cessation in the intervention group than the control group. Another hypothesis to be investigated is that designated intervention messages are effective to reduce the level of SHS participants and their family members exposed to.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Sophia SC Chan, PHD
- Phone Number: 85239176610
- Email: nssophia@hku.hk
Study Locations
-
-
-
Hong Kong, China
- Recruiting
- The University of Hong Kong
-
Principal Investigator:
- Sophia SC Chan, PhD
-
Contact:
- Sophia SC Chan, PHD
- Phone Number: 85239176610
- Email: nssophia@hku.hk
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Hong Kong residents aged 18 or above
- Smoke at least 1 tobacco stick (includes HTP) per day or use e-cigarette daily in the preceding 3-month and verified by exhaled carbon monoxide level of 4ppm (parts per million) or above, assessed by a validated Carbon monoxide Smokerlyzer®
- Living with at least one child of primary 6 or below (aged 12 or below)
- Living with at least one non-smoking family member
- Living in deprived households (monthly household income of less than the median of household monthly income in Hong Kong, HK$ 28,000, or living in subdivided flats or social housing)
- Able to communicate in Chinese (including reading Chinese in IM)
- Able to use the instant messaging tool (e.g., WhatsApp, WeChat) for communication
Exclusion Criteria:
- Those who have communication barriers (either physically or cognitively)
- Those who are currently participating in other smoking cessation programmes or services
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Brief cessation advice + Nicotine replacement Therapy + Instant Messaging + Financial Incentives
Participants will receive a special designed evidence-based intervention using health advice, behavioral and pharmacological support, mobile health technologies, and awareness building (highlight harms) based on the biofeedback results of SHS exposure in the child.
A selected sample of 50 families will receive environmental assessment-derived intervention, including results interpretation and health advice, which will be provided via phone calls for the 50 families within 1 week after the data collection.
|
Ask about smoking history, Warn about the high risk of smoking, Advise to quit as soon as possible, Refer to the smoking cessation services, and Do it again (if the smokers refuse to set a quit date).
Other Names:
1-week sampling of Nicotine Replacement Therapy (NRT) will be provided to support quit attempt.
Full pharmacological treatment (12-week) will be available if needed.
Other Names:
Chat-based mHealth personalized psychosocial and behavioural counselling (smoking cessation and SHS exposure reduction messages will be derived from previously tested interventional studies) using baseline children health and biofeedback data to support quitting throughout the intervention period of 3 months.
Other Names:
A financial incentive (vouchers) of HK$ 500 will be provided for biochemically validated smoking abstinence at 3- and 6-month follow-up.
Considering a possibly low engagement rate of the smokers in mHealth-based support (17% in our previous trial, non-engagement mostly due to busy work), additional HK$ 200 will be provided for participants who actively engaged in the mHealth counselling (defined by have discussed quitting process for >2 times) at 3-month follow-up.
Other Names:
A well-designed self-help booklet will be provided to guide and provide detailed information on smoking cessation.
The contents include information about the benefits of quitting, smoking and diseases, methods to quit, how to handle withdrawal symptoms, declaration of quitting, etc.
Other Names:
In a selected subgroup of 50 families with an additional signed consents, four home visits will be done to: 1. Setup an indoor air quality (IAQ) monitor to collect 24hr air quality data (2 weeks), 2. Collect the monitor for data retrieval, 3. Setup the monitor at 6 months follow-up (2 weeks), 4. Collect the monitor for data retrieval. Environmental assessment derived intervention, including results interpretation and health advice, will be provided via phone calls for the 50 families within 1 week after the data collection. |
|
Active Comparator: Brief cessation advice (AWARD) + Waitlist for same intervention
Participants in the control group will receive the same AWARD brief advice model, self-help booklet at baseline, and financial incentives for validated abstinence at 3- and 6-month follow-up. After the 6-month follow-up, participants who continued to smoke will receive the remaining intervention components: 1-week sampling of NRT and 3 months instant messaging chat-based personalized psychosocial and behavioural counselling for quitting. Participants who validated abstinence at the 12 months or actively engaged in mobile Health counselling will also receive the financial incentives of HK$ 500 and HK$ 200, respectively (waitlist control). Similar to the Intervention group, environmental assessment derived intervention, including results interpretation and health advice, will be provided via phone calls for the 50 families within 1 week after the data collection. |
Ask about smoking history, Warn about the high risk of smoking, Advise to quit as soon as possible, Refer to the smoking cessation services, and Do it again (if the smokers refuse to set a quit date).
Other Names:
A well-designed self-help booklet will be provided to guide and provide detailed information on smoking cessation.
The contents include information about the benefits of quitting, smoking and diseases, methods to quit, how to handle withdrawal symptoms, declaration of quitting, etc.
Other Names:
In a selected subgroup of 50 families with an additional signed consents, four home visits will be done to: 1. Setup an indoor air quality (IAQ) monitor to collect 24hr air quality data (2 weeks), 2. Collect the monitor for data retrieval, 3. Setup the monitor at 6 months follow-up (2 weeks), 4. Collect the monitor for data retrieval. Environmental assessment derived intervention, including results interpretation and health advice, will be provided via phone calls for the 50 families within 1 week after the data collection. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Biochemically validated abstinence
Time Frame: 6-month after recruitment
|
Defined as exhaled carbon monoxide level <4ppm and saliva cotinine level ≤30ng/ml
|
6-month after recruitment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Self-reported 7-day point prevalence quit rate (for smokers)
Time Frame: 3- and 6-month after recruitment
|
Smokers who did not smoke even a puff in the 7 days preceding the follow-up
|
3- and 6-month after recruitment
|
|
Self-reported reduction rate (for smokers)
Time Frame: 3- and 6-month after recruitment
|
Defined by at least 50% reduction in baseline daily number of cigarettes.
|
3- and 6-month after recruitment
|
|
Self-reported intention to quit (for smokers)
Time Frame: 3- and 6-month after recruitment
|
Defined by readiness to quit in 30 days.
|
3- and 6-month after recruitment
|
|
Smoking cessation service use (for smokers)
Time Frame: 3- and 6-month after recruitment
|
The number of calling a hotline of the smoking cessation services, booking an appointment, smoking cessation clinic attendance, and counseling session attendance.
|
3- and 6-month after recruitment
|
|
Self-rated health (for smokers)
Time Frame: 3- and 6-month after recruitment
|
Self-reported health status will be measured using a single-item scale (in general, would you say that your health is excellent, very good, good, fair, or poor?")
|
3- and 6-month after recruitment
|
|
Children's secondhand smoke exposure (for children)
Time Frame: 3- and 6-month after recruitment
|
The children's SHS exposure will be assessed by the nicotine or cotinine level in urine, saliva, or hair using isotope dilution liquid chromatography and tandem mass spectrometry with a limit of detection of < 50 parts per trillion.
|
3- and 6-month after recruitment
|
|
Academic performance (for children)
Time Frame: 3- and 6-month after recruitment
|
Participant's academic performance will be assessed by "In general, would you say your academic performance is Excellent/Very good/Good/Fair/Poor?"
|
3- and 6-month after recruitment
|
|
Cognitive function (for children)
Time Frame: 3- and 6-month after recruitment
|
Participant's cognitive function will be assessed by "In general, would you say your cognitive function is Excellent/Very good/Good/Fair/Poor?"
|
3- and 6-month after recruitment
|
|
Self-reported secondhand smoke exposure (for children and family member)
Time Frame: 3- and 6-month after recruitment
|
Self-reported secondhand smoke exposure will be measured using a single-item scale (In the past week, have you inhaled secondhand smoke in your home?
No or Yes, for___days)
|
3- and 6-month after recruitment
|
|
Quality of life (for smokers and family member)
Time Frame: 3- and 6-month after recruitment
|
Quality of life will be measured by Health-related Quality of life-short form (SF12), which contains eight dimensions (General Health, Physical Function, Role Physical, Bodily Pain, Vitality, Social Functioning, Role Emotional, and Mental Health).
The scale ranges from 0 to 100, with the higher the score, the better and healthier they feel subjectively.
|
3- and 6-month after recruitment
|
|
Depression and anxiety (for smokers, family member and children)
Time Frame: 3- and 6-month after recruitment
|
The Patient Health Questionnaire-4 (PHQ-4) will be used to measure depression and anxiety.
The 4-item questionnaire consists of a 2-item depression sub-scale and 2-item anxiety sub-scale.
The questions are answered on a four-point Likert Scale.
The sum of the scores is categorized into normal (0-2), mild (3-5), moderate (6-8) and severe (9-12).
The total score of 3 or greater on each sub-scale suggest depression or anxiety, respectively.
|
3- and 6-month after recruitment
|
|
Family well-being (for smokers, family member and children)
Time Frame: 3- and 6-month after recruitment
|
Family well-being will be measured by family health, harmony, and happiness (3Hs): three separate questions asked, "How healthy/harmonious/happy do you think your family is?" and will be answered using an 11-point scale ranging from 0 to 10, with higher scores indicating higher level of family well-being.
|
3- and 6-month after recruitment
|
|
Respiratory symptoms (for smokers, family member and children)
Time Frame: 3- and 6-month after recruitment
|
Respiratory symptoms will be measured by a single-item scale (In the past week, if you have had any of the following symptoms, with the response of having trouble with your eyes, sore throat, cough, shortness of breath, runny nose, loss of appetite, and rapid heartbeat).
|
3- and 6-month after recruitment
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- QFK
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Smoking Cessation
-
University of Southern CaliforniaAmerican Cancer Society, Inc.CompletedSmoking | Smoking Cessation | Smoking, Cigarette | Smoking Behaviors | Cessation, SmokingUnited States
-
National University of SingaporeRecruitingSmoking &Amp; Tobacco CessationSingapore
-
Nabi BiopharmaceuticalsNational Institute on Drug Abuse (NIDA)CompletedSmoking | Smoking Cessation | Tobacco CessationUnited States
-
Claremont Graduate UniversityNational Cancer Institute (NCI)CompletedSmoking | Smoking Cessation | Tobacco Use | Tobacco Smoking | Tobacco Use Cessation | Smoking, CigaretteUnited States
-
Emory UniversityNational Cancer Institute (NCI); National Institutes of Health (NIH)Completed
-
Heidelberg UniversityPfizerTerminatedSmoking | Smoking Cessation | Tobacco Use CessationGermany
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedSmoking &Amp; Tobacco CessationUnited States
-
Mayo ClinicNational Institute on Drug Abuse (NIDA)CompletedSmoking | Smoking Cessation | Tobacco Use | Tobacco Smoking | Tobacco Use Cessation | Smoking, Tobacco | Smoking, CigaretteUnited States
-
Sultan Qaboos UniversityCompletedSmoking Cessation | Tobacco Use Cessation | Smoking PreventionOman
-
University of VermontMayo Clinic; Alaska Native Tribal Health ConsortiumTerminatedSmoking | Smoking CessationUnited States
Clinical Trials on Brief cessation advice (AWARD)
-
The University of Hong KongCompleted
-
The University of Hong KongHong Kong Council on Smoking and HealthCompletedSmoking CessationHong Kong
-
The University of Hong KongHong Kong Council on Smoking and HealthCompleted
-
Heidelberg UniversityPfizerTerminatedSmoking | Smoking Cessation | Tobacco Use CessationGermany
-
The University of Hong KongHong Kong Council on Smoking and HealthCompleted
-
Washington University School of MedicineNational Institute on Drug Abuse (NIDA)CompletedSmoking Cessation | Tobacco Use Disorder | Tobacco Use CessationUnited States
-
The University of Hong KongActive, not recruiting
-
The University of Hong KongHong Kong Council on Smoking and HealthRecruiting
-
The University of Hong KongHong Kong Council on Smoking and HealthCompleted